Abstract:OBJECTIVE:To investigate the activation pattern of signal transducers and activators of transcription (STAT) induced by vascular endothelial growth factor (VEGF) in CD34+ hematopoietic progenitor cells, and gain an insight into the molecular mechanism and signal transduction pathway of VEGF that has an effect on CD34+ hematopoietic progenitor cells.METHODS:After isolated from umbilical cord blood by using a high-gradient magnetically activated cell sorting system (MACS), CD34+ cells were stimulated by VEGF (50 ng/ml) for different time (0, 15, 30, 45, 60, 90 min) to detect the tyrosine phosphorylation and nuclear translocation of STAT-3 and STAT-5 with Western blot and immunocytochemistry methods. The expression of VEGF receptor-2 (VEGFR2) on the membrane of CD34+ progenitor cells was examined by immunocytochemistry. ATWLPPR, an effective peptide screened from phage epitope library by affinity for membrane-expressed VEGFR2 and blocking the binding of VEGF to VEGFR2, was used to determine whether the activation of STAT pathway induced by VEGF was blocked.RESULTS:Tyrosine phosphorylation of STAT-3 and STAT-5 was undetectable in unstimulated CD34+ cells, but was evident at 15 min in response to VEGF stimulation. VEGF resulted in a rapid and transient tyrosine phosphorylation of STAT-3 and STAT-5. The maximal tyrosine phosphorylation was catched at 30 and 45 min, respectively (P = 0.0001), and returned to basal levels at 90 min. Immunocytochemistry confirmed that increased phosphorylated STAT-3 was translocated into the nuclei at 30 min (P = 0.0001), and mainly in cytoplasms again at 90 min after stimulation with VEGF. However, compared with unstimulated CD34+ cells, there was only increased phosphorylation of STAT-5 appeared mainly in cytoplasms, but no significant nuclear translocation was found after stimulation with VEGF (P > 0.05). The presence of VEGFR2 was confirmed using anti-VEGFR2 antibody staining by immunocytochemistry, moreover, the phosphorylation of STAT-3 and STAT-5 failed to be activated by the co-culture with ATWLPPR and VEGF, suggesting that activation of the STAT pathway be specifically mediated by VEGFR2 in CD34+ progenitor cells.CONCLUSIONS:STAT signaling pathway participates in the signal transduction of VEGF via VEGFR2 in CD34+ hemopoietic progenitor cells.

Vascular endothelial growth factor (VEGF) and ovarian carcinoma cell supernatant activate signal transducers and activators of transcription (STATs) via VEGF receptor-2 (KDR) in human hemopoietic progenitor cells.

[Activation of Signal Transducers and Activators of Transcription Induced by Vascular Endothelial Growth Factor in CD34+ Hematopoietic Progenitor Cells in Vitro].

[Expressions of VEGF/VEGFRs and Activation of STATs in Ovarian Carcinoma].

VEGF, VEGFRs Expressions and Activated STATs in Ovarian Epithelial Carcinoma

[Phosphorylation of Signal Transducer and Activators of Transcription 3 Induced by Vascular Endothelial Growth Factor in Ovarian Carcinoma Cell Line in Vitro].

Vegf Induces Phosphorylation of Stat3 Through Binding Vegfr2 in Ovarian Carcinoma Cells in Vitro

Bioinformatics Analyses of the Role of Vascular Endothelial Growth Factor in Patients with Non-Small Cell Lung Cancer.

Vascular endothelial growth factor on function of endothelial progenitor cells from peripheral blood

Reactive oxygen species regulate epidermal growth factor-induced vascular endothelial growth factor and hypoxia-inducible factor-1alpha expression through activation of AKT and P70S6K1 in human ovarian cancer cells.

Vegf Induces Proliferation of Human Hair Follicle Dermal Papilla Cells Through Vegfr-2-Mediated Activation of Erk

VEGF165 Modulates Proliferation, Adhesion, Migration and Differentiation of Cultured Human Outer Root Sheath Cells from Central Hair Follicle Epithelium Through VEGFR-2 Activation in Vitro

Vegf Upregulates Vegf Receptor-2 on Human Outer Root Sheath Cells and Stimulates Proliferation Through Erk Pathway

[Effects of Vascular Endothelial Growth Factor on Differentiation and Function of Dendritic Cells Generated from CD34+ Hematopoietic Progenitor Cells in Vitro].

Expression of Soluble Vascular Endothelial Growth Factor Receptor-2 and Its Effect on Proliferation of Vascular Endothelial Cells

Activation of the Pi3k/Akt Pathway Mediates Fsh-Stimulated Vegf Expression in Ovarian Serous Cystadenocarcinoma

Phosphoproteomic Analysis Implicates the Mtorc2-Foxo1 Axis in VEGF Signaling and Feedback Activation of Receptor Tyrosine Kinases.

Effects of PI3K and P42/p44 MAPK on Overexpression of Vascular Endothelial Growth Factor in Hepatocellular Carcinoma.

Autocrinism of vascular endothelial growth factor in human hepatocellular carcinoma cell and its significance

VEGF-D-induced draining lymphatic enlargement and tumor lymphangiogenesis promote lymph node metastasis in a xenograft model of ovarian carcinoma

Gene expression of vascular endothelial growth factor and its receptors in human hematopoietic cells

[Coexpression of Vascular Endothelial Growth Factor and Its Receptors in Human Tumor Cell Lines].